C-Suite

As new products emerge, Indeed says we should expect searches for AI-related postings to rise.

There's a lot going on in the benefits industry right now for advisors to be excited about, including new cost-containment strategies, new technology, new vendors, and new products. And one topic that can't be ignored: the role of AI in the benefits industry.

Becoming a go-to compliance expert requires not just knowledge of the regulatory landscape but also cultivating a relationship of trust.

Allison De Paoli is a relentless advocate for transparent, high-impact employee benefits, driven by the belief that benefits are "not just numbers on a spreadsheet," she rejects the industry's status quo to deliver creative, fiduciary-first solutions that prioritize both fiscal health and human dignity.

Rep. Aaron Bean suggested at a House hearing that clear service price menus might help.

Regeneron will provide Otarmeni — a new gene therapy for an ultra-rare form of genetic hearing loss recently approved by the U.S. Food and Drug Administration — for free under a new agreement with the U.S. government.